GH | Guardant HealthNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$175.00
+$4.27 (+2.50%)

Guardant Health (GH) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2019.

The 50 SMA sits above the 200 on the daily, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $175.00 vs 50 $169.95 / 200 $131.11
Projection
No cross projected
Test
No active test
Last cross
Golden cross 26 Nov 2024 ยท projected 26 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $178.80 vs 50 $126.37 / 200 $57.84
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 1 Sep 2025 ยท projected 29 bars out

4-hour as of 3 Nov 16:00 ET

Price
above both $175.00 vs 50 $170.63 / 200 $162.00
Projection
No cross projected
Test
No active test
Last cross
Golden cross 28 May 2026 ยท projected 29 bars out

Cross history

20
crosses on record since 2019
11 golden9 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
28 May 2026Golden4-hour29 bars outNot tested
11 Mar 2026Death4-hour28 bars outNot tested
week of 1 Sep 2025Golden moderateweekly29 bars outNot tested
20 Jun 2025Golden4-hour30 bars outโ€”
27 May 2025Death4-hour28 bars outโ€”

About GH

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$294M
4-hour coverageYes, since Oct 2025
History on recordSince 2019
SectorHealthcare
Cap bandlarge

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.